{{Cite journal| doi = 10.3389/fcvm.2022.817826| issn = 2297-055X (Print) 2297-055X (Electronic) 2297-055X (Linking)| volume = 9| pages = 817826| last1 = Meihandoest| first1 = T.| last2 = Studt| first2 = J. D.| last3 = Mendez| first3 = A.| last4 = Alberio| first4 = L.| last5 = Fontana| first5 = P.| last6 = Wuillemin| first6 = W. A.| last7 = Schmidt| first7 = A.| last8 = Graf| first8 = L.| last9 = Gerber| first9 = B.| last10 = Amstutz| first10 = U.| last11 = Bovet| first11 = C.| last12 = Sauter| first12 = T. C.| last13 = Asmis| first13 = L. M.| last14 = Nagler| first14 = M.| title = Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study| journal = Front Cardiovasc Med| date = 2022-04-05| pmid = 35369293}}